UBS Group’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Buy |
632,052
+20,524
| +3% | +$69.8K | ﹤0.01% | 3782 |
|
|
2025
Q1 | $2.45M | Sell |
611,528
-54,205
| -8% | -$217K | ﹤0.01% | 3562 |
|
|
2024
Q4 | $4.32M | Buy |
665,733
+646,789
| +3,414% | +$4.2M | ﹤0.01% | 3106 |
|
|
2024
Q3 | $105K | Sell |
18,944
-60,588
| -76% | -$336K | ﹤0.01% | 5133 |
|
|
2024
Q2 | $444K | Sell |
79,532
-3,375
| -4% | -$18.8K | ﹤0.01% | 4003 |
|
|
2024
Q1 | $556K | Buy |
82,907
+82,885
| +376,750% | +$556K | ﹤0.01% | 4015 |
|
|
2023
Q4 | $201 | Sell |
22
-595
| -96% | -$5.44K | ﹤0.01% | 7597 |
|
|
2023
Q3 | $3.41K | Sell |
617
-231,992
| -100% | -$1.28M | ﹤0.01% | 6418 |
|
|
2023
Q2 | $1.99M | Buy |
232,609
+155,295
| +201% | +$1.33M | ﹤0.01% | 2704 |
|
|
2023
Q1 | $711K | Buy |
77,314
+32,198
| +71% | +$296K | ﹤0.01% | 3448 |
|
|
2022
Q4 | $461K | Buy |
45,116
+41,103
| +1,024% | +$420K | ﹤0.01% | 3759 |
|
|
2022
Q3 | $59K | Buy |
4,013
+3,950
| +6,270% | +$58.1K | ﹤0.01% | 5110 |
|
|
2022
Q2 | $1K | Buy |
+63
| New | +$1K | ﹤0.01% | 8795 |
|
|
2021
Q4 | – | Sell |
-831
| Closed | -$18K | – | 9144 |
|
|
2021
Q3 | $18K | Buy |
+831
| New | +$18K | ﹤0.01% | 6132 |
|